New AHRQ Report on C. diff and MDRO Surveillance

As part of AHRQ’s ongoing efforts to advance patient safety, the agency has published a new evidence review to help healthcare leaders prioritize and implement safety strategies. Read the AHRQ Making Healthcare Safer IV report: Active Infection Surveillance of Clostridioides difficile and Multi-Drug Resistant Organisms: Methicillin-Resistant Staphylococcus aureus (MRSA), Carbapenem-Resistant Enterobacterales (CRE), Candida auris.